Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form

About Clarus Therapeutics Holdings, Inc.


  • Ticker CRXT
  • Exchange NASDAQ
  • Shares Outstandng 52,020,700
  • Market Cap $652
  • Description
  • Clarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for pr...
More about CRXT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.